BIOMAT Database Logo BIOMAT Database Logo

[A study on short-course chemotherapy for pulmonary tuberculosis (Report 2)--6--9 month short-course chemotherapy (author's transl)]. 1979

K Yamamoto, and H Aizawa, and I Inoue, and M Sasaoka, and T Suzuki, and K Kameda, and W Yamaguchi, and M Shimada

UI MeSH Term Description Entries
D007538 Isoniazid Antibacterial agent used primarily as a tuberculostatic. It remains the treatment of choice for tuberculosis. Isonicotinic Acid Hydrazide,Ftivazide,Isonex,Isonicotinic Acid Vanillylidenehydrazide,Phthivazid,Phthivazide,Tubazide,Acid Vanillylidenehydrazide, Isonicotinic,Hydrazide, Isonicotinic Acid,Vanillylidenehydrazide, Isonicotinic Acid
D008297 Male Males
D004334 Drug Administration Schedule Time schedule for administration of a drug in order to achieve optimum effectiveness and convenience. Administration Schedule, Drug,Administration Schedules, Drug,Drug Administration Schedules,Schedule, Drug Administration,Schedules, Drug Administration
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000904 Antibiotics, Antitubercular Substances obtained from various species of microorganisms that are, alone or in combination with other agents, of use in treating various forms of tuberculosis; most of these agents are merely bacteriostatic, induce resistance in the organisms, and may be toxic. Antitubercular Antibiotics
D012293 Rifampin A semisynthetic antibiotic produced from Streptomyces mediterranei. It has a broad antibacterial spectrum, including activity against several forms of Mycobacterium. In susceptible organisms it inhibits DNA-dependent RNA polymerase activity by forming a stable complex with the enzyme. It thus suppresses the initiation of RNA synthesis. Rifampin is bactericidal, and acts on both intracellular and extracellular organisms. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p1160) Rifampicin,Benemycin,Rifadin,Rimactan,Rimactane,Tubocin
D013307 Streptomycin An antibiotic produced by the soil actinomycete Streptomyces griseus. It acts by inhibiting the initiation and elongation processes during protein synthesis. Estreptomicina CEPA,Estreptomicina Clariana,Estreptomicina Normon,Strepto-Fatol,Strepto-Hefa,Streptomycin Grünenthal,Streptomycin Sulfate,Streptomycin Sulfate (2:3) Salt,Streptomycin Sulphate,Streptomycine Panpharma,Strepto Fatol,Strepto Hefa

Related Publications

K Yamamoto, and H Aizawa, and I Inoue, and M Sasaoka, and T Suzuki, and K Kameda, and W Yamaguchi, and M Shimada
[Short-course chemotherapy for pulmonary tuberculosis (author's transl)].
September 1981, Kekkaku : [Tuberculosis],
K Yamamoto, and H Aizawa, and I Inoue, and M Sasaoka, and T Suzuki, and K Kameda, and W Yamaguchi, and M Shimada
[Short-course chemotherapy for pulmonary tuberculosis (author's transl)].
August 1978, Kekkaku : [Tuberculosis],
K Yamamoto, and H Aizawa, and I Inoue, and M Sasaoka, and T Suzuki, and K Kameda, and W Yamaguchi, and M Shimada
[Short-course chemotherapy for pulmonary tuberculosis. 2. Evaluation of short-course chemotherapy in experimental murine tuberculosis (author's transl)].
January 1981, Kekkaku : [Tuberculosis],
K Yamamoto, and H Aizawa, and I Inoue, and M Sasaoka, and T Suzuki, and K Kameda, and W Yamaguchi, and M Shimada
[A clinical trial of short-course chemotherapy for pulmonary tuberculosis patients (author's transl)].
November 1974, Kekkaku : [Tuberculosis],
K Yamamoto, and H Aizawa, and I Inoue, and M Sasaoka, and T Suzuki, and K Kameda, and W Yamaguchi, and M Shimada
[Review of short-course chemotherapy for previously untreated pulmonary tuberculosis (author's transl)].
January 1979, Zhonghua jie he he hu xi xi ji bing za zhi = Chinese journal of tuberculosis and respiratory diseases,
K Yamamoto, and H Aizawa, and I Inoue, and M Sasaoka, and T Suzuki, and K Kameda, and W Yamaguchi, and M Shimada
[Controlled clinical trial of three 6 month regimens of chemotherapy for pulmonary tuberculosis (preliminary report) (author's transl)].
May 1978, Kekkaku : [Tuberculosis],
K Yamamoto, and H Aizawa, and I Inoue, and M Sasaoka, and T Suzuki, and K Kameda, and W Yamaguchi, and M Shimada
[Long-term results of short course chemotherapy of pulmonary tuberculosis. Second study-B: results at 6 years after the end of 4-9 month chemotherapy of pulmonary tuberculosis].
October 1987, Kekkaku : [Tuberculosis],
K Yamamoto, and H Aizawa, and I Inoue, and M Sasaoka, and T Suzuki, and K Kameda, and W Yamaguchi, and M Shimada
[Controlled clinical trial of three 6 month regimens of chemotherapy for pulmonary tuberculosis. (Report 2)--Results at one year after completing chemotherapy--(author's transl)].
January 1979, Kekkaku : [Tuberculosis],
K Yamamoto, and H Aizawa, and I Inoue, and M Sasaoka, and T Suzuki, and K Kameda, and W Yamaguchi, and M Shimada
Controlled clinical trial of four short-course (6-month) regimens of chemotherapy for treatment of pulmonary tuberculosis. Second report.
June 1973, Lancet (London, England),
K Yamamoto, and H Aizawa, and I Inoue, and M Sasaoka, and T Suzuki, and K Kameda, and W Yamaguchi, and M Shimada
Practical application of short-course (6 month) regimens of chemotherapy for pulmonary tuberculosis in Kenyan nomads.
March 1979, East African medical journal,
Copied contents to your clipboard!